100
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Intra-Individual Variability in Self-Reported Use of Non-Steroidal Anti-Inflammatory and Analgesic Medicines Depending on Mode of Data Collection - Observations from the Population Study of Women in Gothenburg, Sweden

ORCID Icon, ORCID Icon &
Pages 3243-3250 | Published online: 08 Jul 2021

References

  • Moore N, Pierfitte C, Pehourcq F, Lagnaoui R, Bégaud B. Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects. Clin Pharmacol Ther. 2001;69(6):445–450. doi:10.1067/mcp.2001.116147
  • Dorne JL. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation. Fundam Clin Pharmacol. 2004;18(6):609–620. doi:10.1111/j.1472-8206.2004.00292.x
  • Murali KM, Mullan J, Chen JH, Roodenrys S, Lonergan M. Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: a systematic review. BMC Nephrol. 2017;18(1):42. doi:10.1186/s12882-017-0449-1
  • Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–482. doi:10.1007/s13142-015-0315-2
  • Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735. doi:10.1002/pds.1294
  • Wetzels G, Nelemans P, Schouten J, van Wijk B, Prins M. All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions--an observational study. BMC Health Serv Res. 2006;6(1):8. doi:10.1186/1472-6963-6-8
  • Gama H, Correia S, Lunet N. Questionnaire design and the recall of pharmacological treatments: a systematic review. Pharmacoepidemiol Drug Saf. 2009;18(3):175–187. doi:10.1002/pds.1703
  • West SL. A comparison of data sources for drug exposure ascertainment in pharmacoepidemiologic studies with emphasis on self-reported information. Pharmacoepidemiol Drug Saf. 1997;6(3):215–218. doi:10.1002/(SICI)1099-1557(199705)6:3<215::AID-PDS289>3.0.CO;2-Y
  • Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. A descriptive review of the methodologies used in household surveys on medicine utilization. BMC Health Serv Res. 2008;8(1):222. doi:10.1186/1472-6963-8-222
  • Lewis JD, Strom BL, Kimmel SE, et al. Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf. 2006;15(1):39–45. doi:10.1002/pds.1134
  • West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol. 1995;142(10):1103–1112. doi:10.1093/oxfordjournals.aje.a117563
  • Sundermann AC, Hartmann KE, Jones SH, Torstenson ES, Velez Edwards DR. Validation of maternal recall of early pregnancy medication exposure using prospective diary data. Ann Epidemiol. 2017;27(2):135–139.e132. doi:10.1016/j.annepidem.2016.11.015
  • Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol. 2000;53(3):273–277. doi:10.1016/S0895-4356(99)00167-5
  • Neutel CI, Walop W. Comparing two different approaches to measuring drug use within the same survey. Chronic Dis Can. 2000;21(4):150–156.
  • van den Brandt PA, Petri H, Dorant E, Goldbohm RA, van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci. 1991;13(2):91–96. doi:10.1007/BF01974987
  • Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health (Oxf). 2005;27(3):281–291.
  • Lunet N, Bastos J, Cumaio F, Silva P, Dias E, Barros H. Recall of drug utilization depends on subtle structural questionnaire characteristics. Pharm World Sci. 2008;30(2):175–181. doi:10.1007/s11096-007-9161-8
  • Ademi Z, Turunen JH, Kauhanen J, Enlund H. A comparison of three questionnaire-based measures of analgesic use over 11 years in adult males: a retrospective analysis of data from a prospective, population-based cohort study. Clin Ther. 2007;29(3):529–534. doi:10.1016/S0149-2918(07)80090-7
  • Bengtsson C, Blohmé G, Hallberg L, et al. The study of women in Gothenburg 1968–1969--a population study. General design, purpose and sampling results. Acta Med Scand. 1973;19(4):311–318.
  • Prospective Population Study of Women in Göteborg (PPSW). Swedish national data service. Available from: https://snd.gu.se/en/catalogue/study/snd0009. Accessed March 30, 2021.
  • The RAND Corporation. 36-Item short form survey (SF-36) scoring instructions. Available from: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html. Accessed March 30, 2021.
  • Håkonsen H, Andersson Sundell K, Martinsson J, Hedenrud T. Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market. Health Policy. 2016;120(3):327–333. doi:10.1016/j.healthpol.2016.01.016
  • Hedenrud T, Håkonsen H. Purchase habits, use of paracetamol, and information sources on a reregulated Swedish pharmacy market: a population-based study. Health Policy. 2017;121(1):35–41. doi:10.1016/j.healthpol.2016.11.009
  • Håkonsen H, Wängberg M, Alani D, Hedenrud T. Generic versus brand-name over-the-counter analgesics: knowledge and attitudes among Swedish pharmacy customers. J Pharm Policy Pract. 2020;13(1):60. doi:10.1186/s40545-020-00269-5
  • Krantz E, Wide U, Trimpou P, Bryman I, Landin-Wilhelmsen K. Comparison between different instruments for measuring health-related quality of life in a population sample, the WHO MONICA project, Gothenburg, Sweden: an Observational, Cross-Sectional Study. BMJ Open. 2019;9(4):e024454. doi:10.1136/bmjopen-2018-024454
  • Jönsson S, Hange D. Secular trends in self-assessed health over 24 years among 38-, 50-, 70- and 75-year-old women: observations from the prospective population study of women in Gothenburg. Int J Gen Med. 2020;13:261–270. doi:10.2147/IJGM.S243590
  • Droege M, Maniscalco M, Daniel KL, Baldwin HJ. Consumers’ risk perceptions of prescription and over-the-counter medications. J Pharm Tech. 2007;23(3):142–147. doi:10.1177/875512250702300303
  • Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821–847. doi:10.18433/J3VW2F
  • Tittarelli R, Pellegrini M, Scarpellini MG, et al. Hepatotoxicity of paracetamol and related fatalities. Eur Rev Med Pharmacol Sci. 2017;21(1 Suppl):95–101.
  • Roberts E, Delgado Nunes V, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552–559. doi:10.1136/annrheumdis-2014-206914